CARE FOR ALL:an Evaluation of an asthma QIP - CARE FOR ALL

Study identifier:D589BC00027

ClinicalTrials.gov identifier:NCT05440097

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Change Asthma Clinical Practice through Guideline Education and Implementation For All Patients with Asthma: an Evaluation of an Asthma Quality Improvement Program

Medical condition

asthma

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1500

Study type

Interventional

Age

n/a - n/a

Date

Study Start Date: 29 Jul 2022
Primary Completion Date: 03 Sept 2024
Study Completion Date: 03 Sept 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria